Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03036904
Title Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas (V+DA-EPOCH-R)
Acronym V+DA-EPOCH-R
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital Cancer Center Boston Massachusetts 02284 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Weill Cornell Medicine New York New York 10065 United States Details
Ohio State University Medical Center Columbus Ohio 43210 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field